| RESERVED AREA | LANGUAGE

Lung Cancer Study Group

Sorry, this entry is only available in European Portuguese.

N E W S - A R C H I V E   

Lung cancer reemerges as the most common cancer worldwide

Lung cancer reemerges as the most common cancer worldwide

Lung cancer was the most common in the world in 2022 and the main cause of death from cancer, followed by breast and colorectal cancer, revealed the World Health Organization (WHO). The resurgence of lung cancer as the most common…

GECP warns: 5,000 new cases of lung cancer are diagnosed every year

GECP warns: 5,000 new cases of lung cancer are diagnosed every year

On World Cancer Day, which is celebrated annually on February 4, the Lung Cancer Study Group (GECP) launches a campaign on social media inspired by the initiative of the International Union for Cancer Control (UICC), whose slogan is ” Close…

Clinical Research in Portugal: How are we and where are we going?

Clinical Research in Portugal: How are we and where are we going?

The Colleges of Pharmaceutical Medicine and Clinical Pharmacology of the Order of Doctors are promoting the inquiry “Clinical Research in Portugal: how are we and where are we going?” and what are the greatest difficulties presented by them when the…

12th edition of the “Perspectives in Oncology”

12th edition of the “Perspectives in Oncology”

The 12th edition of the “Perspectives in Oncology” Congress will be held from February 15 to 17, 2024 at Sheraton Porto Hotel, with the scientific sponsorship of the Lung Cancer Study Group (GECP). The organizing committee considers that this is…

Tobacco advertising: 480 thousand euros imposed in fines for infractions

Tobacco advertising: 480 thousand euros imposed in fines for infractions

The Directorate-General for Consumer Affairs (DGC) imposed fines worth 480 thousand euros following the inspection of advertising messages about tobacco and will reinforce these actions regarding the advertising of this heated product, it was announced this Thursday. Heated tobacco has…

News in the treatment of patients with no vested genetic changes

News in the treatment of patients with no vested genetic changes

The last round table of the Autumn Meeting, entitled “News in NSCLC with Actionable Genetic Changes”, was moderated by several experts, including Dr. Marta Soares. By way of summary, the oncologist at IPO Porto states that in this session “new…

6th edition of Lung Cancer Bricks

6th edition of Lung Cancer Bricks

The Faculty of Medicine of the University of Porto, in collaboration with the Centro Hospitalar Universitário de São João and IPATIMUP/i3S, will organize the 6th edition of Lung Cancer Bricks, an innovative advanced, scientific and clinical training program in the…

News in the treatment of patients with no vested genetic changes

News in the treatment of patients with no vested genetic changes

Dr. Fernanda Estevinho closed the “Round Table: New developments in the treatment of patients without Actionable Genetic Changes”, at the Autumn Meeting, by presenting the theme “Subsequent lines”. In this session, the oncologist at Pedro Hispano Hospital spoke about “second-line…

9th Meeting of Immuno-Oncology Pulmonary

9th Meeting of Immuno-Oncology Pulmonary

The 9th Meeting of Pulmonary Immuno-Oncology will take place on January 20th, at Quinta das Tears, in Coimbra, with the scientific sponsorship of the Lung Cancer Study Group (GECP). The meeting dedicated to postgraduate medical formation is received by Prof….

News in the treatment of patients with no vested genetic changes

News in the treatment of patients with no vested genetic changes

The “Round Table: News in the treatment of patients without planetic genetic changes” had as a speaker Dr. Fernando Barata, from the Coimbra Hospital and University Center (Chuc). The expert presented the topic “First Line”, where he addressed the “State…

10-Year Lung Cancer-Specific Survival for Low-Dose CT Persists

10-Year Lung Cancer-Specific Survival for Low-Dose CT Persists

In a study published by the journal Radiology, it was observed that, for an expanded cohort of the International Early Lung Cancer Action Program (I-ELCAP), undergoing annual low-dose computed tomography (LDCT) screening, the survival rate specificity for lung cancer at…